Tendencias21

‘Viewpoint’ addresses IOM report on genome-based therapeutics and companion diagnostics

The promise of personalized medicine is the ability to tailor therapy to the patient’s genome and their cancer’s genome using a series of tests, but the system guiding the development of those tests is complex, and plagued with challenges.

Fuente : http://www.eurekalert.org/pub_releases/2014-02/uov…

RedacciónT21

RedacciónT21

Hacer un comentario